REdI 2024 | D2S03-3 - Q&A Discussion Panel скачать в хорошем качестве

REdI 2024 | D2S03-3 - Q&A Discussion Panel

The second of three Q&A discussion panels for day two of Regulatory Education for Industry (REdI) Annual Conference 2024. **No Timestamps** Speakers: Renu Lal, PharmD, BCACP, RAC-Drugs Lieutenant Commander, US Public Health Service (USPHS) Team Lead, Division of Drug Information (DDI) Deputy Director Small Business and Industry Assistance (SBIA) Office of Communications (OCOMM) Center for Drug Evaluation and Research (CDER) | FDA Alyson Karesh, MD Senior Clinical Advisor Office of Medical Policy (OMP) CDER | FDA Suzanne R. Pattee, JD Regulatory Counsel Office of Clinical Policy (OCP) Office of Clinical Policy and Programs (OCPP) Office of the Commissioner (OC) | FDA Jonathan Resnick Project Management Officer Division of Data Management Services and Solutions (DDMSS) Office of Business Informatics (OBI) Office of Strategic Programs (OSP) CDER | FDA Seyoum Senay Supervisory Operations Research DDMSS | OBI | OSP | CDER | FDA Learn more at: https://www.fda.gov/drugs/news-events... ----------------------- FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research. Upcoming Training - https://www.fda.gov/cdersbia SBIA Listserv - https://public.govdelivery.com/accoun... SBIA 2024 Playlist -    • 2024 CDER Small Business and Industry Assi...   SBIA LinkedIn -   / cder-small-business-and-industry-assistance   SBIA Training Resources - https://www.fda.gov/cdersbialearn Twitter -   / fda_drug_info   Email - CDERSBIA@fda.hhs.gov Phone - (301) 796-6707 I (866) 405-5367